The abstract is read at the publisher; the summary is JClub's.
REDDIE shows that, when real-world data are carefully aligned with study design and analysis, observational diabetes studies can replicate major randomized trial findings and extend them to broader populations.
- Why it matters: Trials can be limited by selective populations, short follow-up, and treatment pathways that differ from routine care, leaving gaps in comparative effectiveness and longer-term outcomes.
- What they did: The REDDIE programme analysed multiple national registries, assessed regulatory expectations, and used target trial emulations of landmark studies alongside modern causal inference methods.
- The result: Well-designed real-world evidence can match key trial results and broaden applicability, but credibility still depends on database fitness and cannot fully remove issues like unmeasured confounding.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.